Market Realist on MSN
How Colossal Biosciences uses CRISPR and the safeguards behind the science
Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
Christos Soteriou was 29 when he needed a quadruple bypass surgery.
By identifying the genes that allow plants to pause growth during stress and restart, we can help ensure crops produce ...
Scientists are on the brink of not just editing our genes to treat diseases, but to enhance humanity – including how much we ...
10hon MSN
Expanded MAGIC toolkit makes genome-wide single-cell mosaic analysis possible in Drosophila
Researchers at Cornell University have developed a powerful new genetic toolkit that allows scientists to study how genes ...
Penn Medicine scientists blend AI and ingenuity to transform mRNA gene editing and personalized therapies redefining modern ...
Fermelanta produces rare plant metabolites via engineered microbes where extraction from plants is costly or not viable.
Kindeva, a global contract development and manufacturing organization and drug delivery innovator, commemorates its 70 years, since the invention of the pressurized metered dose inhaler (pMDI), a ...
Early research using CRISPR technology shows dramatic reductions in cholesterol, raising hopes for a future where a single ...
ETHealthworld.com brings latest infectious disease news, views and updates from all top sources for the Indian Health industry.
Clinical accountability remains firmly with human providers when utilizing new diagnostic technology for midlife women's ...
With AI and massive profits at stake, Silicon Valley executives have shown that they are unwilling to mitigate its dangers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results